Jaume Aguado

7PUBLICATIONS
33CO-AUTHORS
PharmacogenomicsEpidemiological methodsToxicology (incl. clinical toxicology)Cardiology (incl. cardiovascular diseases)Pharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 23, 2026
Evaluating Arrhythmia Risk in Patients with Chronic Obstructive Pulmonary Disease Treated with Aclidinium/Formoterol Fumarate and Other Inhaled Bronchodilators: A Post-Authorization Safety Study.

Cristina Rebordosa, Jaume Aguado, Jennifer Bartsch

|Feb 09, 2026
Effectiveness of Indapamide Prolonged-Release and Perindopril Versus Perindopril Monotherapy for Treated Uncontrolled Hypertension: A Target Trial Emulation.

Céline Darricarrere, Virginie Simon, Manel Pladevall-Vila

|Aug 07, 2024
Effect of different durations of treatment with antihypertensive drugs with anticholinergic effects on the risk of dementia: a target trial emulation study.

Jaume Aguado, Lia Gutierrez, Joan Forns

|Aug 09, 2022
Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists.

Cristina Rebordosa, Estel Plana, Annalisa Rubino

|Mar 23, 2022
Cardiovascular events and all-cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long-acting beta2-agonists.

Cristina Rebordosa, Dóra Körmendiné Farkas, Jukka Montonen

|Mar 15, 2022
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany.

Elena Rivero-Ferrer, Morten Olesen, Estel Plana

Pageof 2

Frequent Collaborators

5 joint publications

Cristina Rebordosa

3 joint publications

Susana Perez-Gutthann

3 joint publications

Núria Saigí-Morgui

3 joint publications

Elena Rivero-Ferrer